PEY Invesco High Yield Equity Dividend Achievers ETF
- 19.510
- -0.150-0.76%
Weekend reading: The latest interview with the founder of Fundsmith, known as the 'British Buffett': Quality is more important than valuation, only excellent companies can continue to provide returns.
If you are not confused by what is happening, then you have not understood it.
Pfizer Stock Traded in the Red for Seven Straight Days
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results.AMMO reported a fourth-quarter profit of 1 cent per share, compared to market expectations for
FDA On June 13 Updates Advice To Manufacturers Of Covid-19 Vaccines (2024-2025 Formula), Says If Feasible Use KP.2 Strain Of JN.1-Lineage
FDA On June 13 Updates Advice To Manufacturers Of Covid-19 Vaccines (2024-2025 Formula), Says If Feasible Use KP.2 Strain Of JN.1-Lineage
How Is The Market Feeling About Pfizer?
Pfizer's (NYSE:PFE) short percent of float has risen 8.06% since its last report. The company recently reported that it has 75.97 million shares sold short, which is 1.34% of all regular shares that a
CDC 'Preparing for the Possibility' Bird Flu Could Spread More Easily
Pfizer's Elrexfio Buoyed by Multiple Myeloma Survival Data
Dividend Roundup: Caterpillar, Oracle, Microsoft, UnitedHealth, and More
Daily Options Tracking | High options volume for Nvidia! Multiple call options earn about double the option premium; Tesla call options are being snapped up.
In three days, Apple's market cap increased by more than 300 billion US dollars, surpassing Microsoft to regain the top spot in the world. The overnight options trading volume for the stock reached 2.41 million contracts, with a call option ratio of 64%. Yesterday, big players were competing to buy Apple's call options expiring on July 19th.
Pfizer's ELREXFIO Shows Median Overall Survival Of More Than Two Years In Phase 2 MagnetisMM-3 Study
Patients in MagnetisMM-3 demonstrated a median overall survival (OS) of 24.6 months, with median progression-free survival (PFS) of 17.2 monthsPfizer Inc. (NYSE:PFE) today announced detailed overall s
FDA Recommends KP.2 Strain Be Used in Updated COVID-19 Shots
3M Analyst Moves To 'Outperform' On Strong EPS Outlook
Wolfe Research's latest analysis of 3M Company (NYSE:MMM) marked a significant upgrade in the company's outlook, shifting the rating from "Peer Perform" to "Outperform" and establishing a robust year-
Altria Group's Options: A Look at What the Big Money Is Thinking
Financial giants have made a conspicuous bearish move on Altria Group.
Charter Communications Most Shorted S&P 500 Communications Stock in May; Alphabet Least Shorted
What's Going On With Pfizer On Thursday? Pharma Giant's Shares Tick Lower
Pfizer Inc. (NYSE:PFE) shares are ticking lower after the company disclosed disappointing results from its Phase 3 CIFFREO study, evaluating the investigational gene therapy for Duchenne muscular dyst
4 Stocks to Watch on Thursday: ADBE, KMB and More
Peeling Back The Layers: Exploring 3M Through Analyst Insights
Throughout the last three months, 17 analysts have evaluated 3M (NYSE:MMM), offering a diverse set of opinions from bullish to bearish.The table below provides a concise overview of recent ratings by
Sarepta Gains After Pfizer's Late-stage Setback for Duchenne Therapy
3M Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/13/2024 22.57% Wolfe Research → $125 Upgrades Peer Perform → Outperform 06/07/2024 17.67% B of A Securi
Pfizer, Flagship to Collaborate on Obesity Drug Discovery